<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35853630</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2542-5641</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Chinese medical journal</Title><ISOAbbreviation>Chin Med J (Engl)</ISOAbbreviation></Journal><ArticleTitle>Epigenome-wide DNA methylation study of whole blood in patients with sporadic amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1466</StartPage><EndPage>1473</EndPage><MedlinePgn>1466-1473</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CM9.0000000000002090</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Epigenetics, and especially DNA methylation, contributes to the pathogenesis of sporadic amyotrophic lateral sclerosis (SALS). This study aimed to investigate the role of DNA methylation in SALS using whole blood of SALS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In total, 32 SALS patients and 32 healthy controls were enrolled in this study. DNA was isolated from whole blood collected from the participants. DNA methylation profiles were generated using Infinium MethylationEPIC BeadChip.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 34 significant differentially methylated positions (DMPs) in whole blood from SALS patients, compared with the healthy controls. Of these DMPs, five were hypermethylated and 29 were hypomethylated; they corresponded to 13 genes. For the DMPs, ATAD3B and BLK were hypermethylated, whereas DDO, IQCE, ABCB1, DNAH9, FIGN, NRP1, TMEM87B, CCSAP, ST6GALNAC5, MYOM2, and RUSC1-AS1 were hypomethylated. We also identified 12 differentially methylated regions (DMRs), related to 12 genes (NWD1, LDHD, CIS, IQCE, TNF, PDE1C, LGALS1, CSNK1E, LRRC23, ENO2, ELOVL2, and ELOVL2-AS1 ). According to data from the Kyoto Encyclopedia of Genes and Genomes database, DNAH9 and TNF are involved in the amyotrophic lateral sclerosis (ALS) pathway. Correlation analysis between clinical features and DNA methylation profiling indicated that the methylation level of ELOVL2 and ARID1B was positively associated with the age of onset ( r &#x200a;=&#x200a;0.86, adjust P &#x200a; = &#x200a;0.001) and disease duration ( r &#x200a;=&#x200a;0.83, adjust P &#x200a; = &#x200a;0.01), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found aberrant methylation in DMP- and DMR-related genes, implying that many epigenetic alterations, such as the hypomethylation of DNAH9 and TNF, play important roles in ALS etiology. These findings can be helpful for developing new therapeutic interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Zhengyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Xinmiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xunzhe</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Liying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Chinese Academy of Medical Sciences, Beijing 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin Med J (Engl)</MedlineTA><NlmUniqueID>7513795</NlmUniqueID><ISSNLinking>0366-6999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037483">Galectin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.2</RegistryNumber><NameOfSubstance UI="D056444">Axonemal Dyneins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.2</RegistryNumber><NameOfSubstance UI="C430745">DNAH9 protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056444" MajorTopicYN="N">Axonemal Dyneins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081122" MajorTopicYN="N">Epigenome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037483" MajorTopicYN="N">Galectin 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>20</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35853630</ArticleId><ArticleId IdType="pmc">PMC9481424</ArticleId><ArticleId IdType="doi">10.1097/CM9.0000000000002090</ArticleId><ArticleId IdType="pii">00029330-990000000-00065</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. . Amyotrophic lateral sclerosis. Lancet 2017; 390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 2018; 17:94&#x2013;102. doi: 10.1016/S1474-4422 (17) 30401-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017; 377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian L, Liu M, Cui L, Guan Y, Liu T, Cui B, et al. . Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in China. J Clin Neurosci 2019; 66:12&#x2013;18. doi: 10.1016/j. jocn.2019.05.036.</Citation><ArticleIdList><ArticleId IdType="pubmed">31155341</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson AS, Hansen J, Thompson S, Gredal O, Weisskopf MG. A mixtures approach to solvent exposures and amyotrophic lateral sclerosis: a population-based study in Denmark. Eur J Epidemiol 2020; 35:241&#x2013;249. doi: 10.1007/s10654-020-00624-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176306</ArticleId><ArticleId IdType="pubmed">32193761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellavia A, Dickerson AS, Rotem RS, Hansen J, Gredal O, Weisskopf MG. Joint and interactive effects between health comorbidities and environmental exposures in predicting amyotrophic lateral sclerosis. Int J Hyg Environ Health 2021; 231:113655.doi: 10.1016/j. ijheh.2020.113655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736520</ArticleId><ArticleId IdType="pubmed">33130429</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Feldman EL. Voicing the need for amyotrophic lateral sclerosis environmental research. JAMA Neurol 2020; 77:543&#x2013;544. doi: 10.1001/jamaneurol.2020.0051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977264</ArticleId><ArticleId IdType="pubmed">32119032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature 2019; 571:489&#x2013;499. doi: 10.1038/s41586-019-1411-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31341302</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 2015; 11:266&#x2013;279. doi: 10.1038/nrneurol.2015.57.</Citation><ArticleIdList><ArticleId IdType="pubmed">25896087</ArticleId></ArticleIdList></Reference><Reference><Citation>Morahan JM, Yu B, Trent RJ, Pamphlett R. A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009; 10:418&#x2013;429. doi: 10.3109/17482960802635397.</Citation><ArticleIdList><ArticleId IdType="pubmed">19922134</ArticleId></ArticleIdList></Reference><Reference><Citation>Chater-Diehl E, Goodman SJ, Cytrynbaum C, Turinsky AL, Choufani S, Weksberg R. Anatomy of DNA methylation signatures: emerging insights and applications. Am J Hum Genet 2021; 108:1359&#x2013;1366. doi: 10.1016/j.ajhg.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387466</ArticleId><ArticleId IdType="pubmed">34297908</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, Hur J, Bender DE, Delaney CE, Cataldo MD, Smith AL, et al. . Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS One 2012; 7:e52672.doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremolizzo L, Messina P, Conti E, Sala G, Cecchi M, Airoldi L, et al. . Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15:98&#x2013;105. doi: 10.3109/21678421.2013.851247.</Citation><ArticleIdList><ArticleId IdType="pubmed">24224837</ArticleId></ArticleIdList></Reference><Reference><Citation>Copped&#xe8; F, Stoccoro A, Mosca L, Gallo R, Tarlarini C, Lunetta C, et al. . Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations. Amyotroph Lateral Scler Frontotemporal Degener 2018; 19:93&#x2013;101. doi: 10.1080/21678421.2017.1367401.</Citation><ArticleIdList><ArticleId IdType="pubmed">28859526</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates N, Pamphlett R. An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler 2007; 8:83&#x2013;86. doi: 10.1080/17482960601149160.</Citation><ArticleIdList><ArticleId IdType="pubmed">17453634</ArticleId></ArticleIdList></Reference><Reference><Citation>Garton FC, Benyamin B, Zhao Q, Liu Z, Gratten J, Henders AK, et al. . Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort. Mol Genet Genomic Med 2017; 5:418&#x2013;428. doi: 10.1002/mgg3.302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5511806</ArticleId><ArticleId IdType="pubmed">28717666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Xi Z, Ghani M, Jia P, Pal M, Werynska K, et al. . Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28. J Neurol Neurosurg Psychiatry 2016; 87:1268&#x2013;1270. doi: 10.1136/jnnp-2016-313592.</Citation><ArticleIdList><ArticleId IdType="pubmed">27154192</ArticleId></ArticleIdList></Reference><Reference><Citation>Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, Martin LJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci 2011; 31:16619&#x2013;16636. doi: 10.1523/JNEUROSCI.1639-11.2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3238138</ArticleId><ArticleId IdType="pubmed">22090490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, Schiavo G, et al. . A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005; 169:561&#x2013;567. doi: 10.1083/jcb.200501085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171702</ArticleId><ArticleId IdType="pubmed">15911875</ArticleId></ArticleIdList></Reference><Reference><Citation>Maimon R, Ankol L, Gradus Pery T, Altman T, Ionescu A, Weissova R, et al. . A CRMP4-dependent retrograde axon-to-soma death signal in amyotrophic lateral sclerosis. EMBO J 2021; 40:e107586.doi: 10.15252/embj.2020107586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408612</ArticleId><ArticleId IdType="pubmed">34190355</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L, Allodi I, Nichterwitz S, Nizzardo M, Simone C, Corti S, et al. . Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience 2015; 291:216&#x2013;229. doi: 10.1016/j.neuroscience.2015.02.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidotti G, Scarlata C, Brambilla L, Rossi D. Tumor necrosis factor alpha in amyotrophic lateral sclerosis: Friend or foe? Cells 2021; 10:518.doi: 10.3390/cells10030518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8000008</ArticleId><ArticleId IdType="pubmed">33804386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>